96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1502Ang (1-7) derivative oligopeptides and methods for using and producing the same
#1503PEPTIDE ANTIBIOTIC COMPLEXES AND METHODS OF USE THEREOF
#1504Compositions for inducing urinary voiding and defecation
#1505Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1506Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1507Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1508Therapeutic DLL4 Binding Proteins
#1509Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#1510Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#1511Peptide-based cancer imaging agents
#1512LIGAND-CONJUGATES AND METHODS FOR TARGETED RECEPTOR-MEDIATED CELLULAR UPTAKE
#1513Peptide oligonucleotide conjugates
#1514Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#1515Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#1516System and method for identification and characterization of transglutaminase species
#1517Peptide agonists and antagonists of TLR4 activation
#1518Alpha conotoxin peptides
#1519SYNTHESIS OF ICATIBANT
#1520SPHERICAL NUCLEIC ACIDS (SNAS) WITH SHEDDABLE PEG LAYERS
#1521AMYLOID CONJUGATE AND USES AND METHODS THEREOF
#1522Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
#1523CHLAMYDIA SUIS DIAGNOSIS
#1524Ras inhibitory peptides and uses thereof
#1525NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
#1526Anticancer peptides and uses thereof
#1527Macrocyclic broad spectrum antibiotics
#1528Nanoparticle conjugates and uses thereof
#1529Flavivirus peptide sequences, epitopes, and methods and uses thereof
#1530Methods for treating pseudoxanthoma elasticum (PXE)
#1531Artifical nucleases comprising engineered cleavage half-domains
#1532Antimicrobial adhesive protein, antimicrobial nanoparticle, antimicrobial composition comprising same nanoparticle, and preparation method for same composition
#1533Synthetic binder of breast cancer stem cells
#1534Peptide inhibitors of tight junction permeability
#1535Castration resistant prostate cancer
#1536Therapeutic targeting of SET1B/compass pathway for treating cancers
#1537DPEP-1 binding agents and methods of use
#1538TISSUE OCCLUDING AGENT
#1539Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1540Integrin Antagonists
#1541Peptides for treatment and prevention of hyperglycaemia
#1542Antibacterial Compounds Produced by the Microorganism Strain Corallococcus Coralloides ST201330 (DSM 24989)
#1543Tau aggregation peptide inhibitors
#1544Method of treatment
#1545ANTIMICROBIAL PEPTIDES
#1546Methods and compositions related to inhibition of viral entry
#1547Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes
#1548Antibodies and peptides to treat HCMV related diseases
#1549Disulfide bond containing compounds and uses thereof
#1550PARTNER OF SLD FIVE 1 (PSF1)-DERIVED PEPTIDE
#1551JNK Inhibitor Molecules For Treatment Of Various Diseases
#1552Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1553Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1554Treatment agent for lysosomal storage disease
#1555Antibacterial compositions, methods of making and use thereof
#1556Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1557Ultrasound-sensitive peptide particles for spatially resolved molecule delivery
#1558EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY
#1559Microcapsule including peptide having cell receptor binding affinity and cosmetic composition containing same
#1560Tumor associated monocyte/macrophage binding peptide and methods of use thereof
#1561LASSO STRUCTURES AND THEIR SYNTHESIS
#1562Targeting α2δ-1-bound glutamate receptors for treating diseases and disorders
#1563Therapeutic peptides
#1564MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same
#1565Flounder surimi having antioxidant and antihypertensive effects and method of preparing the same
#1566Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1567Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1568Method for imparting body taste to food
#1569PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#1570Recrystallization inhibitor
#1571STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF
#1572Beta-2-glycoprotein 1 derived peptide and use thereof for treating antiphospholipid syndrome
#1573FUSION POLYPEPTIDE AND METHOD FOR PRODUCING FUSION POLYPEPTIDE
#1574Peptide compound and application thereof, and composition containing peptide compound
#1575INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION
#1576PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#1577Saposin-A derived peptides and uses thereof
#1578Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1579Compositions comprising D-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies
#1580Cyclic peptides targeting alpha-4-beta-7 integrin
#1581Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#1582Molecular imaging of cancer cells in vivo
#1583Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1584Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1585MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
#1586PEPTIDES HAVING OSTEOBLAST GROWTH-PROMOTING ACTIVITY AND USE THEREOF
#1587Modulation of Wnt5a to Treat Glaucoma
#1588Cell permeable cyclic peptide scaffolds
#1589Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#1590Polypeptide derived from CAP1 and pharmaceutical composition comprising same as effective ingredient
#1591CONTROLLED MODULATION OF AMINO ACID SIDE CHAIN LENGTH OF PEPTIDE ANTIGENS
#1592ANTIMICROBIAL PEPTIDOMIMETICS
#1593Selective CXCR4 binding peptide conjugate and methods for making and using the same
#1594Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1595Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1596Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1597Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1598KOC1-derived peptide and vaccine including same
#1599Hornerin: a novel non-VEGF mediated angiogenic protein expressed in both human and mouse angiogenic endothelial cells and human pancreatic cancer cells
#1600VITAMIN RECEPTOR DRUG DELIVERY CONJUGATES FOR TREATING INFLAMMATION
#1601Anti-PVRIG antibodies and methods of use
#1602Anti-inflammatory use of peptide
#1603Peptide showing melanogenesis promoting activity and use thereof
#1604PEPTIDE VACCINE AND PEPTIDE VACCINE COMPOSITION FOR CRANIAL NERVE DISEASE
#1605CRISPR-BASED GENOME MODIFICATION AND REGULATION
#1606ALZHEIMER'S DISEASE TREATMENT METHOD
#1607Peptide libraries with non-canonical amino acids
#1608BMP-2-binding peptide amphiphile nanofibers
#1609Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1610Compositions for treating pathological calcification conditions, and methods using same
#1611Micropeptides and use of same for modulating gene expression
#1612POLYPEPTIDE WITH TUMOUR BINDING ACTIVITY
#1613COMBINATORIAL SYNTHESIS AND BIOMARKER DEVELOPMENT
#1614Peptides and methods and uses thereof for modulating anaphase promoting complex (APC) activity
#1615Method for immobilizing lectin
#1616PEPTIDES AND NEMATICIDAL COMPOSITIONS
#1617Modulation of complement activity
#1618Treatment of haematological malignancies
#1619Acetylcholine receptor-binding peptide
#1620Peptide Libraries and Methods of Use
#1621DRUG DELIVERY CONJUGATES CONTAINING UNNATURAL AMINO ACIDS AND METHODS FOR USING
#1622HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
#1623Telomerase polypeptide vaccine for treating cancer
#1624Method for detecting food spoilage microbes
#1625Anti-HIV peptides
#1626Immunogenic compounds for cancer therapy
#1627AGONISTS OF GUANYLATE CYCLASE USEFUL FOR DOWNREGULATION OF PRO-INFLAMMATORY CYTOKINES
#1628Anti-microbial peptides
#1629Short synthetic peptide and uses thereof
#1630Polypeptide and use thereof
#1631Radiotherapeutic and companion imaging agents to target MC1R
#1632Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1633Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1634PEPTIDE REAGENTS AND METHODS FOR DETECTION AND TARGETING OF DYSPLASIA, EARLY CANCER AND CANCER
#1635ANGIOTENSIN-1-RECEPTOR ANTAGONISTS
#1636Compositions for mitigating hydrogen sulfide contamination using a recombinant protein with an affinity tag fused to a hydrogen sulfide scavenging enzyme
#1637Compositions for mitigating hydrogen sulfide contamination using a recombinant protein with an affinity tag fused to a hydrogen sulfide scavenging enzyme
#1638Prevention of tissue ischemia and related methods
#1639Peptides and compositions for prevention of cell adhesion and methods of using same
#1640Peptides capable of reactivating p53 mutants
#1641Melanocortin Receptor Ligands
#1642Methods of using GM6 in diagnosing and treating Alzheimers disease
#1643Mesothelin vaccines and model systems
#1644Peptides and combination of peptides for use in immunotherapy against various cancers
#1645Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#1646Use for JNK inhibitor molecules for treatment of various diseases
#1647Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1648URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME
#1649Relaxin1 derived peptides for use in immunotherapy
#1650B*44 restricted peptides for use in immunotherapy against cancers and related methods
#1651Selective recovery
#1652Modulation of P53 for the treatment of cancer
#1653Composition for autophagy inhibiting in cell, and pharmaceutical composition for preventing or treating tumor disease, or inhibiting anti-cancer agents resistance containing the same
#1654PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS
#1655Adiponectin peptidomimetics for treating ocular disorders
#1656Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1657Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1658Antibodies binding to TLR2/TLR4-interacting immunologically active polypeptide
#1659Use of peptide compounds for promoting survival, growth and cell differentiation
#1660Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker Patient
#1661Immunotherapy for angiogenic disease
#1662Inhibitors of prototypic galectin dimerization and uses thereof
#1663Uterine cancer treatments
#1664ANTIMICROBIAL PEPTIDES
#1665THERAPEUTIC PEPTIDES
#1666METHOD OF PRODUCING NANOPARTICLE DEVICE USING PRINT-ON HYDROGEL
#1667COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING
#1668Composition for improving hair health
#1669FLUOROPHORE-BASED KINASE SENSORS
#1670In vivo protein N-acylation
#1671YAP PROTEIN INHIBITING POLYPEPTIDE AND APPLICATION THEREOF
#1672Peptides and compositions for prevention of cell adhesion and methods of using same
#1673Peptide inhibitors of transcription factor aggregation
#1674Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
#1675NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF
#1676PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#1677Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#1678MODIFIED PEPTOIDS
#1679SUBSTRATES RECOGNIZED BY FIBROBLAST ACTIVATION PROTEIN (FAP) AND METHODS OF USING THE SAME
#1680Method of treating with a peptide
#1681Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1682Engineered cascade components and cascade complexes
#1683Peptide having anti-obesity and anti-diabetes efficacy and use thereof
#1684Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#1685Multivalent ligand-lipid constructs
#1686Methods for removing bacterial toxins from a biological fluid
#1687Peptides whose uptake in cells is controllable
#1688Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1689POLYPEPTIDE SPERM STABILISER FOR SEMEN USED IN ARTIFICIAL INSEMINATION
#1690HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject
#1691Peptides and combination of peptides for use in immunotherapy against various tumors
#1692IL-2Rγ binding compounds
#1693IL-2RBeta binding compounds
#1694Epitope tag and method for detection and/or purification of tagged polypeptides
#1695PSMA-specific binding proteins
#1696Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
#1697Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1698Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1699Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1700Peptides and combination of peptides for use in immunotherapy against various tumors
#1701MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION
#1702Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
#1703Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1704Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1705Immunotherapy against several tumors including lung cancer
#1706Immunotherapy against several tumors including lung cancer
#1707PEPTIDE INHIBITORS OF SODIUM CHANNELS
#1708Building blocks for stapled peptides
#1709Peptides and combination of peptides for use in immunotherapy against various tumors
#1710MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#1711Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#1712Immunotherapy for angiogenic disease
#1713Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment
#1714Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory
#1715Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1716Growth Hormone Releasing Peptides
#1717Probiotic molecules for reducing pathogen virulence
#1718Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#1719Compositions and methods for regulating blood pressure
#1720Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1721Glypican-3 peptide reagents and methods
#1722Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments
#1723SYNTHESIS OF MULTIPHOSPHORYLATED PEPTIDES
#1724Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1725Modulation of complement activity
#1726Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
#1727COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES
#1728Dual mass spectrometry-cleavable crosslinking reagents for protein-protein interactions
#1729Heat shock protein-binding peptide compositions and methods of use thereof
#1730Peptides and combination of peptides for use in immunotherapy against various cancers
#1731*03 restricted peptides for use in immunotherapy against cancers and related methods
#1732A*03 restricted peptides for use in immunotherapy against cancers and related methods
#1733Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1734Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1735Fusion peptide comprising thrombus-targeting peptide, ferritin fragment and thrombolytic peptide, and use thereof
#1736Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1737IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS
#1738Interferon Analogs
#1739Peptide inhibitors targeting the pivotal anaerobic respiration factor AniA
#1740Cancer vaccine composition
#1741Ang (1-7) derivative oligopeptides for the treatment of pain
#1742Peptides and compositions for use in cosmetics
#1743Assessment of stability of biological product in prefilled syringes
#1744Methods and compositions for the treatment of cancer
#1745Cyclin G1 inhibitors and related methods of treating cancer
#1746Dual functional novel peptide having cell permeability and bone tissue regeneration ability, and use thereof
#1747PEPTIDE HAVING MELANOGENESIS-INHIBITING ACTIVITY AND COMPOSITION COMPRISING SAME
#1748Zinc-binder based EBNA1-specific compounds
#1749Cyclic peptide epitopes and small-molecule mimics for inducing autophagy
#1750Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1751Immunostimulatory method
#1752IMMUNE SYSTEM MODULATORS
#1753METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE AND DISC TISSUE PATHOLOGIES
#1754NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF
#1755Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1756SELECTIVE PEPTIDE INHIBITORS OF FRIZZLED
#1757Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof
#1758Central nervous system homing peptides and uses thereof
#1759Compositions comprising peptide WKDEAGKPLVK
#1760INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#1761Antimicrobial peptides with wound healing activity
#1762Method for preparing AMG 416 (etelcalcetide)
#1763BRAIN TARGETING LONG-ACTING PROTEIN CONJUGATE
#1764Compositions and methods for cancer imaging and radiotherapy
#1765ANG (1-7) DERVIATIVE OLIGOPEPTIDES FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS
#1766METHODS FOR INHIBITING NONALCOHOLIC STEATOHEPATITIS, NONALCOHOLIC FATTY LIVER DISEASE, AND/OR DE NOVO LIPOGENESIS
#1767TARGETED ANTICOAGULANT
#1768Peptide-HLA complexes and methods of producing same
#1769LIPOLANTHIPEPTIDES AND THEIR USES AS ANTIMICROBIAL AGENTS
#1770Peptoid compound, and derivative, salt, preparation method and use thereof
#1771Peptidomimetic macrocycles
#1772PRODUCTION METHOD FOR NONCYCLIC PEPTIDE-NUCLEIC ACID COMPLEX HAVING, AT N-TERMINAL, AMINO ACID WITH THIOL GROUP NEAR AMINO GROUP, LIBRARY THEREOF, AND CYCLIC PEPTIDE-NUCLEIC ACID COMPLEX LIBRARY DERIVED FROM SAME
#1773Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1774Cell penetrating peptides with improved internalization properties
#1775PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF
#1776Peptoid affinity ligands
#1777Oligopeptide search method, oligopeptide, modified peptide, and immunoassay method
#1778Immunomodulatory peptide
#1779PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#1780AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#1781Polypeptide binding to a plurality of amyloid monomers and aggregates, and use thereof
#1782Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
#1783Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1784Immunotherapy against melanoma and other cancers
#1785Immunotherapy against melanoma and other cancers
#1786Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#1787Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#1788Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1789Antiviral immunotropic agent for the treatment of acute respiratory viral infections
#1790Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1791Immunotherapy against neuronal and brain tumors
#1792METHOD FOR ENHANCING EXTRACELLULAR VESICLE PRODUCTION
#1793Complexes for gene deletion and editing
#1794SMALL CATIONIC ANTI-BIOFILM AND IDR PEPTIDES
#1795Peptides capable of reactivating p53 mutants
#1796Tyrosine peptide cross-linked biocompatible hydrogel and method of production
#1797Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1798Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1799VAP polypeptide and use thereof in preparation of drug for targeted diagnosis and treatment of tumor
#1800Methods and compositions for refining molybdenum mineral